Insider Name | Buy/Sell | Company Name | Ticker | Amount | Shares Change | |||
---|---|---|---|---|---|---|---|---|
Jan 10, 2022 | Jan 12, 2022 | Mackay Martin CEO | Buy | Rallybio Corp | RLYB | $10.35 | $103,473 | +1.37% |
Feb 27, 2017 | Mar 02, 2017 | Mackay Martin EVP Global Head of R D | Sell | Alexion Pharmaceuticals Inc | ALXN | $131.63 | $244,170 | -3.53% |
Feb 09, 2017 | Feb 10, 2017 | Mackay Martin EVP Global Head of R D | Sell | Alexion Pharmaceuticals Inc | ALXN | $126.84 | $27,524 | -0.54% |
Feb 06, 2017 | Feb 08, 2017 | Mackay Martin EVP Global Head of R D | Sell | Alexion Pharmaceuticals Inc | ALXN | $125.7 | $342,904 | -6.39% |
May 16, 2016 | May 18, 2016 | Mackay Martin EVP Global Head of R D | Sell | Alexion Pharmaceuticals Inc | ALXN | $139.2 | $570,284 | -8.76% |
Feb 29, 2016 | Mar 01, 2016 | Mackay Martin EVP Global Head of R D | Sell | Alexion Pharmaceuticals Inc | ALXN | $138.91 | $138,910 | -2.09% |
Feb 05, 2016 | Feb 09, 2016 | Mackay Martin EVP Global Head of R D | Sell | Alexion Pharmaceuticals Inc | ALXN | $139.98 | $569,858 | -9.08% |
Aug 03, 2015 | Aug 05, 2015 | Mackay Martin EVP Global Head of R D | Sell | Alexion Pharmaceuticals Inc | ALXN | $196.52 | $9M | -56.94% |
May 14, 2015 | May 22, 2015 | Mackay Martin EVP Global Head of R D | Sell | Alexion Pharmaceuticals Inc | ALXN | $160.33 | $650,298 | -10.98% |
Mar 02, 2015 | Mar 04, 2015 | Mackay Martin EVP Global Head of R D | Sell | Alexion Pharmaceuticals Inc | ALXN | $180.34 | $66,726 | -0.99% |
Feb 10, 2015 | Feb 13, 2015 | Mackay Martin EVP Global Head of R D | Sell | Alexion Pharmaceuticals Inc | ALXN | $173.97 | $677,956 | -10.79% |
Nov 03, 2014 | Nov 04, 2014 | Mackay Martin EVP Global Head of R D | Sell | Alexion Pharmaceuticals Inc | ALXN | $191.52 | $2M | -27.74% |
Jun 12, 2014 | Jun 13, 2014 | Mackay Martin EVP Global Head of R D | Sell | Alexion Pharmaceuticals Inc | ALXN | $166.42 | $4M | -50.58% |
May 14, 2014 | May 15, 2014 | Mackay Martin EVP Global Head of R D | Sell | Alexion Pharmaceuticals Inc | ALXN | $160.85 | $574,878 | -12.76% |